The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS - PubMed (original) (raw)
Review
The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS
S J O'Brien et al. Immunol Rev. 2000 Oct.
Abstract
The pivotal discovery that two chemokine receptors, CCR5 and CXCR4, serve along with the T-cell receptor-interacting CD4 molecule as the principal co-receptors for HIV-1 entry stimulated a search for common genetic polymorphism in their genes which might affect the course of AIDS. Four mutational variants, CCR5-delta32, CCR5-P1, CCR2-641 and SDF1-3'A were discovered to play a regulatory role in HIV-1 infection, in the rate of progression to AIDS or both. Plausible physiological mechanisms to explain the population genetic association by these alleles have been advanced and are discussed critically here. Genetic ablation of AIDS progression by chemokine receptor and ligand gene variants has catalyzed development of novel therapies targeting the virus-co-receptor interaction. The functional and therapeutic implications of these AIDS restriction genes for disease progression and intervention are explored in this review.
Similar articles
- Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC).
Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O'Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, O'Brien SJ. Winkler C, et al. Science. 1998 Jan 16;279(5349):389-93. doi: 10.1126/science.279.5349.389. Science. 1998. PMID: 9430590 - Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
Verma R, Gupta RB, Singh K, Bhasin R, Anand Shukla A, Chauhan SS, Luthra K. Verma R, et al. J Clin Virol. 2007 Mar;38(3):198-203. doi: 10.1016/j.jcv.2006.12.006. Epub 2007 Jan 19. J Clin Virol. 2007. PMID: 17240189 - Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O'Brien SJ. Smith MW, et al. Science. 1997 Aug 15;277(5328):959-65. doi: 10.1126/science.277.5328.959. Science. 1997. PMID: 9252328 - Chemokines and chemokine receptors in susceptibility to HIV-1 infection and progression to AIDS.
Chatterjee A, Rathore A, Vidyant S, Kakkar K, Dhole TN. Chatterjee A, et al. Dis Markers. 2012;32(3):143-51. doi: 10.3233/DMA-2011-0874. Dis Markers. 2012. PMID: 22377730 Free PMC article. Review.
Cited by
- Legacy of a magic gene-CCR5-∆32: From discovery to clinical benefit in a generation.
OBrien SJ. OBrien SJ. Proc Natl Acad Sci U S A. 2024 Mar 19;121(12):e2321907121. doi: 10.1073/pnas.2321907121. Epub 2024 Mar 8. Proc Natl Acad Sci U S A. 2024. PMID: 38457490 Free PMC article. - Modelling the impact of protein-kinase R allelic variant on HIV biomarkers trajectories by means of latent class mixed models.
Brombin C, Bagaglio S, Cugnata F, Castagna A, Uberti-Foppa C, Salpietro S, Di Serio C, Morsica G. Brombin C, et al. Sci Rep. 2022 Nov 3;12(1):18575. doi: 10.1038/s41598-022-23289-4. Sci Rep. 2022. PMID: 36329104 Free PMC article. - The Potential Use of the CRISPR-Cas System for HIV-1 Gene Therapy.
Sanches-da-Silva GN, Medeiros LFS, Lima FM. Sanches-da-Silva GN, et al. Int J Genomics. 2019 Aug 21;2019:8458263. doi: 10.1155/2019/8458263. eCollection 2019. Int J Genomics. 2019. PMID: 31531340 Free PMC article. Review. - CCR5 status and metastatic progression in colorectal cancer.
Suarez-Carmona M, Chaorentong P, Kather JN, Rothenheber R, Ahmed A, Berthel A, Heinzelmann A, Moraleda R, Valous NA, Kosaloglu Z, Eurich R, Wolf J, Grauling-Halama S, Hundemer M, Lasitschka F, Klupp F, Kahlert C, Ulrich A, Schneider M, Falk C, Jäger D, Zoernig I, Halama N. Suarez-Carmona M, et al. Oncoimmunology. 2019 Jul 13;8(9):e1626193. doi: 10.1080/2162402X.2019.1626193. eCollection 2019. Oncoimmunology. 2019. PMID: 31428524 Free PMC article. - Single-Nucleotide Polymorphisms in Human NPC1 Influence Filovirus Entry Into Cells.
Kondoh T, Letko M, Munster VJ, Manzoor R, Maruyama J, Furuyama W, Miyamoto H, Shigeno A, Fujikura D, Takadate Y, Yoshida R, Igarashi M, Feldmann H, Marzi A, Takada A. Kondoh T, et al. J Infect Dis. 2018 Nov 22;218(suppl_5):S397-S402. doi: 10.1093/infdis/jiy248. J Infect Dis. 2018. PMID: 30010949 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials